PRESS RELEASE published on 08/27/2024 at 11:48, 2 months 25 days ago Inside Information / Other news releases Arkema discloses share buyback transactions from 19 to 23 August 2024, in compliance with EU regulation. More details on the company's website Transactions Share Buyback Investor Relations EU Regulation ARKEMA
BRIEF published on 08/20/2024 at 11:37, 3 months 1 day ago Arkema Announces Share Buyback Transactions for August 2024 Share Buyback Investor Relations EU Regulations ARKEMA August 2024
PRESS RELEASE published on 08/20/2024 at 11:32, 3 months 1 day ago Inside Information / Other news releases Arkema discloses trading in own shares from 12 to 16 August 2024 in compliance with regulations. Total of 16,658 shares bought back. More details on Arkema's website Share Buyback Investor Relations Trading Compliance ARKEMA
BRIEF published on 08/13/2024 at 11:02, 3 months 8 days ago Arkema Announces Share Buyback Transactions for Early August 2024 Share Buyback Investor Relations EU Regulations Stock Market ARKEMA
PRESS RELEASE published on 08/13/2024 at 10:57, 3 months 8 days ago Inside Information / Other news releases Arkema discloses share buyback transactions from 05 August to 09 August 2024 in compliance with EU regulations. For detailed info, visit Arkema's investor relations website Share Buyback Investor Relations Compliance EU Regulations ARKEMA
BRIEF published on 08/06/2024 at 15:06, 3 months 15 days ago Arkema Announces Share Buyback Transactions Share Buyback Financial Transactions Stock Market EU Regulation ARKEMA
PRESS RELEASE published on 08/06/2024 at 15:01, 3 months 15 days ago Inside Information / Other news releases Arkema discloses trading own shares buyback transactions from 29 July to 02 August 2024, in compliance with regulations Trading Compliance Regulations Shares Buyback ARKEMA
BRIEF published on 08/06/2024 at 14:57, 3 months 15 days ago Arkema Discloses Share and Voting Right Figures Voting Rights French Commercial Code Shares AMF ARKEMA
PRESS RELEASE published on 08/06/2024 at 14:52, 3 months 15 days ago Inside Information / Other news releases Press release on the total number of shares and voting rights as per French commercial code and AMF regulations Voting Rights French Commercial Code Shares AMF Regulated Information
BRIEF published on 07/16/2024 at 14:31, 4 months 5 days ago Arkema Discloses Recent Share Buyback Transactions Share Buyback Financial Transactions XPAR Market ARKEMA July 2024
Published on 11/21/2024 at 16:30, 1 hour 7 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 36 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 37 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 37 minutes ago Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 37 minutes ago Isaac Ullatil Joins Wellstack Board of Directors
Published on 11/21/2024 at 15:41, 1 hour 55 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 06:58, 10 hours 39 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 17 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 23 hours 52 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 23 hours 52 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 9 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
